LongueVue Capital Invests in Pinnacle Clinical Research

Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

January 10, 2023

Healthcare Services

Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.

LongueVue Capital Invests in Summit Clinical Research

October 26, 2022

Healthcare Services

LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.

Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute

February 28, 2025

Healthcare Services

LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.

Pinnacle Clinical Research Acquires Jubilee Clinical Research

September 27, 2024

Healthcare Services

LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.

Pinnacle Clinical Research Adds Five Sites to Network (KMC, CRCNJ, Bellaire, Palmetto, DRI)

June 18, 2024

Healthcare Services

Pinnacle Clinical Research, a portfolio company of LongueVue Capital, has acquired or partnered with five clinical research sites — Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute — expanding Pinnacle’s network to 12 U.S. sites. The transactions broaden Pinnacle’s geographic footprint and add CNS/Alzheimer’s and metabolic disease capabilities, strengthening the platform’s ability to serve sponsors and underrepresented patient populations.

LongueVue Capital Invests Growth Capital in Select Express & Logistics

February 5, 2019

Transportation

LongueVue Capital made a growth capital investment in Select Express & Logistics, a New York–headquartered provider of last-mile, white-glove delivery and assembly services. LVC partnered with Select Express's existing management team (which remains a significant shareholder) to support the company’s continued national expansion and capability build-out across retail, e-commerce and other end markets.